183 related articles for article (PubMed ID: 28858131)
21. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
Gentry CA; Campbell DL; Williams RJ
Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
[TBL] [Abstract][Full Text] [Related]
22. Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile.
Turner NA; Warren BG; Gergen-Teague MF; Addison RM; Addison B; Rutala WA; Weber DJ; Sexton DJ; Anderson DJ
Clin Infect Dis; 2022 Mar; 74(4):648-656. PubMed ID: 34017999
[TBL] [Abstract][Full Text] [Related]
23. [Two cases of liver abscess caused by Clostridium perfringens after transcatheter arterial chemoembolization].
Oshima S; Takaishi K; Tani N; Hirano M; Ikeda K; Makari Y; Hoshi M; Doi T; Kobori Y; Kurokawa E; Tamura S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1795-7. PubMed ID: 24393925
[TBL] [Abstract][Full Text] [Related]
24. Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.
Stevens VW; Khader K; Echevarria K; Nelson RE; Zhang Y; Jones M; Timbrook TT; Samore MH; Rubin MA
Clin Infect Dis; 2020 Jul; 71(3):645-651. PubMed ID: 31504328
[TBL] [Abstract][Full Text] [Related]
25. [A case of a gas-forming liver abscess caused by Clostridium perfringens after transcatheter arterial chemoembolization].
Takemura K; Sekoguchi S; Yamane S; Yamaguchi K; Oaku T; Hotta Y; Yamada N; Isozaki Y; Nagao Y; Oyamada H; Maeda K; Itou T
Nihon Shokakibyo Gakkai Zasshi; 2018; 115(6):554-562. PubMed ID: 29887591
[TBL] [Abstract][Full Text] [Related]
26. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
[TBL] [Abstract][Full Text] [Related]
27. Liver abscess and bacteremia caused by lactobacillus: role of probiotics? Case report and review of the literature.
Sherid M; Samo S; Sulaiman S; Husein H; Sifuentes H; Sridhar S
BMC Gastroenterol; 2016 Nov; 16(1):138. PubMed ID: 27863462
[TBL] [Abstract][Full Text] [Related]
28. Clostridium perfringens liver abscess after pancreatic resection.
Tabarelli W; Bonatti H; Cejna M; Hartmann G; Stelzmueller I; Wenzl E
Surg Infect (Larchmt); 2009 Apr; 10(2):159-62. PubMed ID: 19388837
[TBL] [Abstract][Full Text] [Related]
29. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin.
Wilcox MH; Howe R
J Antimicrob Chemother; 1995 Oct; 36(4):673-9. PubMed ID: 8591942
[TBL] [Abstract][Full Text] [Related]
30. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
Bouza E; Alcalá L; Marín M; Valerio M; Reigadas E; Muñoz P; González-Del Vecchio M; de Egea V
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
[TBL] [Abstract][Full Text] [Related]
31. Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection.
Hung YP; Lin HJ; Wu CJ; Chen PL; Lee JC; Liu HC; Wu YH; Yeh FH; Tsai PJ; Ko WC
Anaerobe; 2014 Dec; 30():24-6. PubMed ID: 25102472
[TBL] [Abstract][Full Text] [Related]
32. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
[TBL] [Abstract][Full Text] [Related]
33. Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.
Bossé D; Lemire C; Ruel J; Cantin AM; Ménard F; Valiquette L
Infection; 2013 Apr; 41(2):579-82. PubMed ID: 22996384
[TBL] [Abstract][Full Text] [Related]
34. Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
Manthey CF; Eckmann L; Fuhrmann V
Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1239-1250. PubMed ID: 28766951
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for Recurrent Clostridioides Difficile Infection in Children.
Lee P; Nemati K; Silver EJ; Cacace J; Goldman DL
Hosp Pediatr; 2023 Nov; 13(11):1010-1017. PubMed ID: 37877183
[TBL] [Abstract][Full Text] [Related]
36. Toxigenic
Khodaparast S; Mohabati Mobarez A; Khoramabadi N; Vasei M; Saberifiroozi M
Epidemiol Infect; 2021 Aug; 149():e250. PubMed ID: 34372951
[TBL] [Abstract][Full Text] [Related]
37. Seeing C. diff Differently: A Case of Clostridioides difficile Bacteremia in Metastatic Melanoma.
Vasser MM; Ayisire E
Am J Case Rep; 2020 Nov; 21():e928169. PubMed ID: 33250508
[TBL] [Abstract][Full Text] [Related]
38. Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas.
Aitken SL; Joseph TB; Shah DN; Lasco TM; Palmer HR; DuPont HL; Xie Y; Garey KW
PLoS One; 2014; 9(7):e102848. PubMed ID: 25057871
[TBL] [Abstract][Full Text] [Related]
39. [A case of epidural abscess occurred after liver abscess complicated by transarterial chemoembolization in a patient with metastatic cancer to liver].
Lee YJ; Kim GH; Park DY; Kim S; Park CJ; Kim TK; Koh JH
Korean J Gastroenterol; 2013 Apr; 61(4):225-9. PubMed ID: 23624738
[TBL] [Abstract][Full Text] [Related]
40. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial.
Johnson S; Homann SR; Bettin KM; Quick JN; Clabots CR; Peterson LR; Gerding DN
Ann Intern Med; 1992 Aug; 117(4):297-302. PubMed ID: 1322075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
